Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2008 5
2009 2
2010 3
2011 1
2012 3
2013 1
2014 1
2015 3
2016 4
2017 4
2018 1
2020 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.
Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U. Sorbye H, et al. Among authors: vestermark lw. Ann Oncol. 2013 Jan;24(1):152-60. doi: 10.1093/annonc/mds276. Epub 2012 Sep 11. Ann Oncol. 2013. PMID: 22967994 Free article.
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A, Sorbye H, Elvebakken H, Perren A, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Ladekarl M, Tabaksblat EM, Knappskog S. Venizelos A, et al. Among authors: vestermark lw. Endocr Relat Cancer. 2023 Aug 23;30(10):e230057. doi: 10.1530/ERC-23-0057. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37410378 Free article.
UFT (tegafur-uracil) in rectal cancer.
Casado E, Pfeiffer P, Feliu J, González-Barón M, Vestermark L, Jensen HA. Casado E, et al. Among authors: vestermark l. Ann Oncol. 2008 Aug;19(8):1371-1378. doi: 10.1093/annonc/mdn067. Epub 2008 Apr 1. Ann Oncol. 2008. PMID: 18381370 Free article. Review.
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H. Morken S, et al. Among authors: vestermark lw. Br J Cancer. 2023 Dec;129(12):1930-1939. doi: 10.1038/s41416-023-02462-0. Epub 2023 Oct 23. Br J Cancer. 2023. PMID: 37872405 Free PMC article. Clinical Trial.
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
Elvebakken H, Perren A, Scoazec JY, Tang LH, Federspiel B, Klimstra DS, Vestermark LW, Ali AS, Zlobec I, Myklebust TÅ, Hjortland GO, Langer SW, Gronbaek H, Knigge U, Tiensuu Janson E, Sorbye H. Elvebakken H, et al. Among authors: vestermark lw. Neuroendocrinology. 2021;111(9):883-894. doi: 10.1159/000511905. Epub 2020 Oct 1. Neuroendocrinology. 2021. PMID: 33002892
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
Ali AS, Grönberg M, Federspiel B, Scoazec JY, Hjortland GO, Grønbæk H, Ladekarl M, Langer SW, Welin S, Vestermark LW, Arola J, Österlund P, Knigge U, Sorbye H, Grimelius L, Janson ET. Ali AS, et al. Among authors: vestermark lw. PLoS One. 2017 Nov 7;12(11):e0187667. doi: 10.1371/journal.pone.0187667. eCollection 2017. PLoS One. 2017. PMID: 29112960 Free PMC article.
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP, Ladekarl M, Garresori H, Hjortland GO, Sundlöv A, Galleberg R, Knigge P, Kjaer A, Langer SW, Knigge U. Pommergaard HC, et al. Among authors: vestermark lw. J Neuroendocrinol. 2021 May;33(5):e12967. doi: 10.1111/jne.12967. Epub 2021 Mar 26. J Neuroendocrinol. 2021. PMID: 33769624
Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M, Langer SW, Grønbæk H, Österlund P, Hjortland GO, Assmus J, Tang L, Perren A, Sorbye H. Galleberg RB, et al. Among authors: vestermark lw. Eur J Surg Oncol. 2017 Sep;43(9):1682-1689. doi: 10.1016/j.ejso.2017.04.010. Epub 2017 May 4. Eur J Surg Oncol. 2017. PMID: 28522174
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial.
Hagman H, Frödin JE, Berglund Å, Sundberg J, Vestermark LW, Albertsson M, Fernebro E, Johnsson A. Hagman H, et al. Among authors: vestermark lw. Ann Oncol. 2016 Jan;27(1):140-7. doi: 10.1093/annonc/mdv490. Epub 2015 Oct 19. Ann Oncol. 2016. PMID: 26483047 Free article. Clinical Trial.
28 results